SCHEMBL20845238

SCHEMBL20845238

C1=C\c2ccc(-c3nc(-c4ccccc4)nc(-c4cc(-c5ccccc5)cc(-c5ccccc5)c4)n3)cc2-c2ccc3ccccc3c2Sc2ccccc2-c2ccccc2/1

nearest known ligand 0.32

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ TP53 P04637 2/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ HSD17B10 Q99714 2/20 0.32
▸ MAPT P10636 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ TSHR P16473 1/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ NFKB2 Q00653 1/20 0.32
▸ RELA Q04206 1/20 0.32
▸ ATM Q13315 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ MEN1 O00255 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20845242 0.97 SMN1; SMN2 (0.34) KDM4EALDH1A1TP53SMN1; SMN2HSD17B10
SCHEMBL20845240 0.96 KDM4E (0.34) KDM4EALDH1A1TP53SMN1; SMN2HSD17B10
SCHEMBL20845056 0.96 MAPT (0.34) KDM4EALDH1A1TP53SMN1; SMN2HSD17B10
SCHEMBL20845333 0.95 KDM4E (0.33) KDM4EALDH1A1TP53SMN1; SMN2HSD17B10
SCHEMBL20845092 0.90 HPGD (0.34) KDM4EALDH1A1TP53SMN1; SMN2HSD17B10
SCHEMBL20845249 0.89 RAB9A (0.37) KDM4EALDH1A1TP53SMN1; SMN2HSD17B10
SCHEMBL20222638 0.89 MAPT (0.35) KDM4EALDH1A1TP53SMN1; SMN2HSD17B10
SCHEMBL20845250 0.89 ALDH1A1 (0.36) KDM4EALDH1A1TP53SMN1; SMN2HSD17B10
SCHEMBL20845322 0.87 MEN1 (0.34) KDM4EALDH1A1SMN1; SMN2HSD17B10MAPT
SCHEMBL20222636 0.86 MEN1 (0.37) KDM4EALDH1A1TP53SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190092745-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2019-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190092745-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME SCO2, AOX1, ORC3 KDM4E 631/4885ALDH1A1 981/4885TP53 3777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback